A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Conditions
Chronic Kidney Disease · Renal Anemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Site BE32002, Brussels, Belgium
Site BE32001, Edegem, Belgium
Site BE32004, Ghent, Belgium
Site BE32003, Leuven, Belgium
Site BG35901, Sofia, Bulgaria
Site HR38501, Zagreb, Croatia
Site HR38503, Zagreb, Croatia
Site CZ42002, Brno, Czechia
Site CZ42001, Prague, Czechia
Site DK45001, Aarhus, Denmark
Site FI35801, Helsinki, Finland
Site DE49001, Tübingen, Germany
Site GR30002, Athens, Greece
Site GR30001, Thessaloniki, Greece
Site IE35301, Dublin, Ireland
Site IT39003, Milan, Italy
Site IT39004, Padova, Italy
Site LB96101, El Achrafiyé, Lebanon
Site LT37001, Vilnius, Lithuania
Site NL31002, Rotterdam, Netherlands
Site NO47002, Oslo, Norway
Site PL48003, Krakow, Poland
Site PL48002, Warsaw, Poland
Site RO40002, Clug Napoca, Romania
Site RO40001, Timișoara, Romania
Site SA96602, Dammam, Saudi Arabia
Site SA96601, Riyadh, Saudi Arabia
Site SK42101, Bratislava, Slovakia
Site ES34003, Esplugues de Llobregat, Spain
Site SP34001, Madrid, Spain
Site SE46002, Mölnlycke, Sweden
Site SE46003, Mölnlycke, Sweden
Site TR90001, Ankara, Turkey (Türkiye)
Site TR90007, Ankara, Turkey (Türkiye)
Site TR90010, Ankara, Turkey (Türkiye)
Site TR90003, Istanbul, Turkey (Türkiye)
Site TR90008, Istanbul, Turkey (Türkiye)
Site TR90005, İzmit, Turkey (Türkiye)
Site TR90006, Kayseri, Turkey (Türkiye)
Site TR90002, Manisa, Turkey (Türkiye)
Site GB44005, Cardiff, United Kingdom
Site GB44006, Glasgow, United Kingdom
Site GB44008, Liverpool, United Kingdom
Site GB44007, London, United Kingdom
Site GB44003, Newcastle upon Tyne, United Kingdom
Site GB44001, Nottingham, United Kingdom
Site GB44004, Southampton, United Kingdom
Study leads
Medical Monitor
Study Director
Astellas Pharma Global Development, Inc.